Cara Therapeutics Inc. sell Bank of America Co.
Start price
07.03.23
/
50%
€6.39
Target price
07.03.24
-
Performance (%)
-84.51%
End price
08.03.24
€0.99
Summary
This prediction ended on 08.03.24 with a price of €0.99. Bank_of_America_Co_ correctly predicted massive losses of -84.51% for Cara Therapeutics Inc.. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cara Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 3.023% | 2.202% | 14.664% | 48.878% |
| iShares Nasdaq 100 | 3.561% | 1.325% | 31.410% | 83.744% |
| iShares Nikkei 225® | 6.618% | 5.707% | 49.420% | 60.392% |
| iShares S&P 500 | 2.635% | 1.008% | 25.116% | 61.272% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Cara Therapeutics Inc. diskutieren
Cara Therapeutics, Inc. (NASDAQ: CARA) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating.
Ratings data for CARA provided by MarketBeat
In the thread Trading Cara Therapeutics Inc.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten